文献速递中医内科中药与中成药合理使用

冠心V通过TGF-β1与波形蛋白相互作用保护急性心肌梗死后心室重构

Guanxin V protects against ventricular remodeling after acute myocardial infarction through the interaction of TGF-β1 and Vimentin.
PubMed 文献 · Phytomedicine · 2021-11-28

本研究在叙利亚仓鼠急性心肌梗死后的心室重构模型中评价冠心V的疗效,并在心肌细胞重构模型中探索机制。结果显示冠心V减轻凋亡、心肌肥厚和心室重构并改善心功能,其作用通过直接靶向TGF-β1并阻碍TGF-β1与波形蛋白的相互作用实现。

要点

  • 冠心V可减轻急性心肌梗死后心室重构并改善心功能。
  • 冠心V抗重构作用依赖于直接靶向TGF-β1。
  • TGF-β1与波形蛋白相互作用可能是心室重构的新靶点。

核心结论

  • 冠心V可能通过靶向TGF-β1并阻碍其与波形蛋白的相互作用来对抗心室重构。

研究设计与样本

  • 在叙利亚仓鼠中构建急性心肌梗死后心室重构模型,并建立心肌细胞重构模型。
  • 采用超声心动图和生化指标评价心脏功能与重构,用透射电镜观察心肌细胞超微结构。
  • 通过RT-qPCR和免疫印迹检测信号通路关键标志物,用慢病毒过表达TGF-β1验证其必要性,并用免疫共沉淀检测TGF-β1与波形蛋白的相互作用。

主要发现

  • 在急性心肌梗死诱导的仓鼠心脏重构中,冠心V减轻凋亡、心肌肥厚和心脏重构,甚至改善心脏功能。
  • 机制上冠心V通过直接靶向TGF-β1抑制重构过程,过表达TGF-β1加重心室重构而冠心V可逆转此失调。
  • 冠心V降低病理心室重构中上调的波形蛋白水平,免疫共沉淀证实波形蛋白与TGF-β1存在相互作用且冠心V阻碍该相互作用。

临床怎么用

  • 冠心V可作为针对TGF-β1及其与波形蛋白相互作用通路对抗心室重构的潜在药物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Our previous study demonstrated that Guanxin V (GXV), a traditional Chinese herbal medicine, has a significant therapeutic effect on ventricular remodeling. However, the mechanistic action of GXV in ventricular remodeling warrants clarification. PURPOSE: Here, we aimed to explore the anti-ventricular remodeling contribution of GXV and to provide an experimental basis for clinical generalization. METHODS: A ventricular remodeling model after acute myocardial infarction was constructed in Syrian hamsters. The echocardiography and biochemical indices of cardiac function and remodeling were evaluated in different groups. Moreover, we built a remodeling model in cardiomyocytes and further explored the mechanism. Transmission electron microscopy was used to observe the ultrastructure of cardiomyocytes. The vital markers involved in the signaling pathway were detected by RT-qPCR and immunoblotting. Transforming growth factor beta 1 (TGF-β1) was overexpressed with lentivirus to verify the necessity of TGF-β1 in GXV's anti-ventricular remodeling effect. Finally, co-immunoprecipitation was conducted to test the interaction of TGF-β1 and Vimentin. RESULTS: In hamster cardiac remodeling induced by acute myocardial infarction, GXV alleviated apoptosis, cardiac hypertrophy, and cardiac remodeling, and even improved cardiac function. Mechanistically, GXV inhibited the remodeling process by directly targeting TGF-β1. Overexpression of TGF-β1 exacerbated the ventricular remodeling, whereas GXV reversed this dysregulation. GXV also decreased the up-regulated Vimentin level in pathological ventricular remodeling. Moreover, the interaction of Vimentin and TGF-β1 was confirmed by co-immunoprecipitation, and GXV impeded this interaction. CONCLUSION: We showed that the interaction of Vimentin and TGF-β1 may be a novel target for ventricular remodeling and that GXV might be a new agent to fight against ventricular remodeling by targeting TGF-β1 and impeding its interaction with Vimentin.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Liang B, Zhang XX, Li R, et al. Guanxin V protects against ventricular remodeling after acute myocardial infarction through the interaction of TGF-β1 and Vimentin. Phytomedicine. 2021. PMID: 34883417. doi:10.1016/j.phymed.2021.153866

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。